|
|
Volumn 7, Issue 13, 2001, Pages 1199-1212
|
|
Vinflunine, a second generation novel Vinca alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for future mitotic blockers
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIMITOTIC AGENT;
ANTINEOPLASTIC ALKALOID;
CISPLATIN;
COLCHICINE;
DOXORUBICIN;
ESTRAMUSTINE;
FLUOROURACIL;
MICROTUBULE ASSOCIATED PROTEIN;
MITOMYCIN C;
NAVELBINE;
TAXANE DERIVATIVE;
TUBULIN;
VINBLASTINE;
VINCA ALKALOID;
VINCRISTINE;
VINDESINE;
VINFLUNINE;
VINLEUROSINE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CONTROLLED STUDY;
DRUG MECHANISM;
DRUG RESISTANCE;
DRUG STRUCTURE;
DRUG TARGETING;
DRUG UPTAKE;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
MICROTUBULE ASSEMBLY;
MITOSIS INHIBITION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN INTERACTION;
TUMOR VASCULARIZATION;
TUMOR XENOGRAFT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MICROTUBULES;
TUBULIN;
VINBLASTINE;
|
|
EID: 0034858240
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: 10.2174/1381612013397456 Document Type: Article |
|
Times cited : (54)
|
|
References (48)
|
